“IVF is a fragile and complicated process with many variables; things like handling and transferring embryos from dish to dish, even the air quality in a lab can affect the result. Our technology allows for much greater precision and consistency, meaning we can offer women and couples with fertility issues a better chance of getting pregnant and having a healthy baby.” Jeremy Thompson, Fertilis Co-founder & CSO
Highlights
Australian Fertilis raises $2M for its micro medical devices that automate embryo culturing and improve IVF success rates.
Miteralaunches two new at-home genetic tests for pregnancy to screen for conditions like Down Syndrome.
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
